Search results for: 'research-area pi3k-akt-signaling'
- PD 169316Catalog No. :A8689P38 MAPK inhibitor
PD169316, a p38 MAPK inhibitor, abrogates signaling initiated by both TGFbeta and Activin A, but not bone morphogenetic protein (BMP) 4.
- LY2228820Catalog No. :A5566P38 MAP kinase inhibitorLY2228820 is a potent, selective, ATP-competitive small-molecule inhibitor inhibiting α- and β-isoforms of p38 MAPK with IC(50) values of 5.3nM and 3.2 nM, respectively .
- SB202190 (FHPI)Catalog No. :A1632P38 MAPK inhibitor
SB202190 (FHPI) is a potent p38 MAPK inhibitor that specifically inhibits p38α and p38β with IC50 values of 50 and 100 nM, respectively .
- SB 203580Catalog No. :A8254P38 MAP kinase inhibitor
SB203580, also called 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl) 1Himidazole , is a specific pyridinyl imidazole inhibitor of p38-MAPK (Mitogen-activated Protein Kinase) signaling pathway  .